New drug is first to help patients with recurrent low-grade ovarian cancer

Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/4...